X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
microbiology (17) 17
index medicus (15) 15
antifungal agents - pharmacology (12) 12
echinocandins - pharmacology (11) 11
pharmacology & pharmacy (11) 11
humans (9) 9
drug resistance, fungal (8) 8
mechanisms of resistance (8) 8
microbial sensitivity tests (8) 8
fungal proteins - genetics (7) 7
resistance (7) 7
antifungal agents - therapeutic use (6) 6
bacterial infections and mycoses (6) 6
micafungin (6) 6
susceptibility (6) 6
caspofungin (5) 5
drug resistance, fungal - genetics (5) 5
echinocandins (5) 5
echinocandins - therapeutic use (5) 5
invasive candidiasis (5) 5
albicans (4) 4
antifungal agents (4) 4
antifungal drug-resistance (4) 4
echinocandin resistance (4) 4
epidemiology (4) 4
female (4) 4
glucosyltransferases - genetics (4) 4
infectious diseases (4) 4
mutation (4) 4
adult (3) 3
aged (3) 3
amphotericin-b (3) 3
antifungal resistance (3) 3
aspergillus fumigatus (3) 3
candida (3) 3
candida - drug effects (3) 3
candida albicans - drug effects (3) 3
candida glabrata (3) 3
candida glabrata - drug effects (3) 3
candida glabrata - genetics (3) 3
candidiasis - drug therapy (3) 3
dosage and administration (3) 3
glabrata (3) 3
male (3) 3
microbial sensitivity tests - methods (3) 3
mortality (3) 3
mutation - genetics (3) 3
mycology (3) 3
research (3) 3
triazoles (3) 3
1,3-beta-d-glucan synthase (2) 2
aged, 80 and over (2) 2
analysis (2) 2
animals (2) 2
antifungal drugs (2) 2
antifungals (2) 2
aspergillosis (2) 2
aspergillus fumigatus - drug effects (2) 2
aspergillus fumigatus - genetics (2) 2
azole (2) 2
azole resistance (2) 2
azoles (2) 2
beta-glucans - metabolism (2) 2
cancer (2) 2
candida albicans - genetics (2) 2
candida auris (2) 2
candidemia - microbiology (2) 2
candidiasis - microbiology (2) 2
changing epidemiology (2) 2
chitin (2) 2
clinical-practice (2) 2
drug resistance, fungal - drug effects (2) 2
drug therapy (2) 2
echinocandin (2) 2
erg11 (2) 2
fks mutations (2) 2
fluconazole (2) 2
genes (2) 2
genes, fungal (2) 2
genetic aspects (2) 2
hematology (2) 2
immunology (2) 2
lipopeptides - pharmacology (2) 2
membrane proteins - genetics (2) 2
middle aged (2) 2
molecular sequence data (2) 2
mutant proteins - genetics (2) 2
mutation, missense (2) 2
mutations (2) 2
phenotype (2) 2
polycyclic compounds (2) 2
reduced susceptibility (2) 2
saccharomyces-cerevisiae (2) 2
surveillance (2) 2
1-aminobenzotriazole (1) 1
[ sdv.mp.myc ] life sciences [q-bio]/microbiology and parasitology/mycology (1) 1
abstracts (1) 1
adolescent (1) 1
amino acid sequence (1) 1
amino acid substitution (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Infectious Diseases, ISSN 1058-4838, 6/2013, Volume 56, Issue 12, pp. 1724 - 1732
Journal Article
Frontiers in Microbiology, ISSN 1664-302X, 2016, Volume 7, p. 1995
Journal Article
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 10/2018, Volume 62, Issue 10
Multiple Erg11 amino acid substitutions were identified in clinical isolates of originating from India and Colombia. Elevated azole MICs were detected in upon... 
Antifungal resistance | ERG11 | Candida auris | Azoles | Reduced azole susceptibility
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 12/2012, Volume 56, Issue 12, pp. 6121 - 6131
Journal Article
Antimicrobial agents and chemotherapy, ISSN 0066-4804, 01/2019, Volume 63, Issue 1
Candida auris is an emerging multidrug-resistant yeast that can cause serious invasive infections. The accurate and rapid assessment of antifungal resistance... 
Candida auris | echinocandin | ERG11 | resistance | azole | FKS | molecular beacons | MICROBIOLOGY | PHARMACOLOGY & PHARMACY
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 09/2017, Volume 61, Issue 9
SCY-078 is an orally active antifungal whose target is the beta-(1,3)-D-glucan synthase (GS). We evaluated the spontaneous emergence of SCY-078-resistant... 
Resistance | SCY-078 | Candida glabrata | ANTIFUNGAL DRUGS | MK-3118 | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | resistance
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 2017, Volume 65, Issue 2, pp. 216 - 225
Background: Azole-resistant aspergillosis in high-risk patients with hematological malignancy or hematopoietic stem cell transplantation (HSCT) is a cause of... 
hematology | resistance | aspergillosis | in vitro | azole | INFECTIOUS DISEASES | ANTIFUNGAL DRUG-RESISTANCE | PREEXPOSURE | MICROBIOLOGY | IMMUNOLOGY | AZOLE RESISTANCE | DISEASE | MUTATIONS | FUMIGATUS | Aspergillus | Care and treatment | Triazoles | Analysis | Aspergillosis | Outcome and process assessment (Health Care) | Research | Major
Journal Article
Journal of Clinical Microbiology, ISSN 0095-1137, 07/2015, Volume 53, Issue 7, pp. 2037 - 2041
A rapid molecular-based assay for the detection of theCandida albicans FKS1gene mutations responsible for resistance to echinocandin drugs was designed and... 
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 10/2018, Volume 62, Issue 10
APX001 is a first-in-class, intravenous and orally available, broadspectrum antifungal agent in clinical development for the treatment of life-threatening... 
Efficacy | 1-aminobenzotriazole | APX001 | Pharmacokinetics | Candida | APX001A | VITRO ACTIVITY | GLABRATA | MICAFUNGIN | MECHANISM | E1210 | MICROBIOLOGY | BROAD-SPECTRUM ANTIFUNGAL |